SCHEDULE: Bio-Rad Laboratories Founder's Family Maintains Significant Control Through Class A and B Stock Holdings

An amended Schedule 13D filing reveals Alice N. Schwartz and her revocable trust continue to hold substantial Class A and Class B common stock, solidifying family control over Bio-Rad Laboratories, primarily for estate planning purposes.

Summary

• Alice N. Schwartz beneficially owns 2,732,073 shares of Bio-Rad Laboratories Class A Common Stock, representing 12.3% of the outstanding Class A shares.
• The Alice N. Schwartz Revocable Trust holds 1,781,356 shares of Class A Common Stock, accounting for 8.0% of the outstanding Class A shares.
• These percentages are based on 22,142,422 Class A shares outstanding as of April 28, 2025.
• Alice N. Schwartz also has beneficial ownership of 4,554,564 shares of Class B Common Stock, representing 89.8% of the outstanding Class B shares.
• The Alice N. Schwartz Revocable Trust directly owns 437,510 shares of Class B Common Stock, representing 8.6% of the outstanding Class B shares.
• Class B percentages are based on 5,070,184 Class B shares outstanding as of April 28, 2025.
• The primary purpose of recent transactions (gifts of shares) by Alice N. Schwartz and her revocable trust has been for estate planning.
• Alice N. Schwartz, along with other family members, maintains control over the management of Bio-Rad Laboratories through their significant Class B Common Stock ownership.
• David Schwartz, Bio-Rad's former Chairman and Alice N. Schwartz's husband, is deceased.

Sentiment

Score: 6

Explanation: The filing is neutral to slightly positive, confirming stable family control and routine estate planning. It provides clarity on ownership structure but does not contain new information that would significantly alter the company's operational or financial outlook. The continued strong family control could be viewed positively for long-term stability but negatively for external shareholder influence.

Positives

• The filing confirms stable, long-term family control, which can provide consistent strategic direction for the company.
• Estate planning activities indicate a structured approach to wealth management and succession for the controlling family.

Negatives

• Concentrated family control, particularly through Class B shares, limits the influence of other shareholders on corporate governance and strategic decisions.
• The ongoing gifting of shares, while for estate planning, represents a gradual reduction in direct beneficial ownership by Alice N. Schwartz, though control remains.

Risks

• Concentrated Control: Alice N. Schwartz and her family control 89.8% of Class B Common Stock, which grants disproportionate voting power and could lead to decisions that may not align with the interests of all Class A shareholders.
• Succession Risk: The significant control held by Alice N. Schwartz, a Director Emeritus, introduces potential succession risks related to the future leadership and strategic direction of the company.

Future Outlook

The filing primarily details current ownership structure and past transactions for estate planning purposes, with no explicit forward-looking statements or guidance regarding the company's future operations or financial performance.

Management Comments

• The purpose of the Shareholders' ownership of Bio-Rad shares has been control of the Company.
• Mrs. Schwartz, along with other members of her family, control the management of the Company and may be deemed to be a 'parent' of the Company.
• By virtue of her Class B Common Stock ownership, Mrs. Schwartz, along with other members of her family, control the management of the Company and may be deemed to be a 'control person' of the Company.

Industry Context

This Schedule 13D amendment primarily concerns the internal ownership and control structure of Bio-Rad Laboratories, a life science research and clinical diagnostics company. It does not provide information directly related to broader industry trends, competitive landscape, or market position, but rather reinforces the long-standing family control model common in some established companies.

Comparison to Industry Standards

• The document focuses on the ownership structure of Bio-Rad Laboratories, specifically the significant control maintained by the Schwartz family through their Class B common stock holdings.
• This dual-class share structure, while not uncommon in certain industries or for founder-led companies (e.g., Google, Meta, Ford), deviates from the one-share, one-vote standard preferred by many institutional investors and corporate governance advocates.
• Companies like Alphabet (Google) and Meta Platforms (Facebook) also utilize dual-class structures to allow founders to retain control despite public ownership, which can be seen as both a strength (stable long-term vision) and a weakness (limited shareholder democracy).
• No specific comparable companies or projects are mentioned in the filing itself for direct comparison of results.

Management Changes

Corporate Governance

Legal Proceedings

• Neither Alice N. Schwartz nor the Alice N. Schwartz Revocable Trust has been convicted in a criminal proceeding or been a party to a civil proceeding related to federal or state securities laws in the last five years.

Related Party Transactions

• Gifts of Class A Common Stock were made by Alice N. Schwartz and the Alice N. Schwartz Revocable Trust to the Alles Institute for Medical Research, a Delaware Charitable Nonstock Corporation, with respect to which Alice N. Schwartz shares voting and dispositive power.

Stakeholder Impact

• Shareholders: Confirms continued concentrated control by the Schwartz family, potentially limiting the influence of Class A shareholders on strategic decisions and corporate governance.
• Management/Employees: Indicates stable leadership and strategic direction due to long-term family control.
• Creditors/Suppliers: No direct impact indicated, as the filing is about ownership structure, not financial health or operational changes.

Next Steps

• Continued management of Bio-Rad Laboratories by the Schwartz family.
• Ongoing estate planning activities by Alice N. Schwartz, potentially involving further share transfers to trusts or charitable entities.

Key Dates

Recommendation

Keywords

Bio-Rad Laboratories, SEC Filing, Schedule 13D, Share Ownership, Class A Common Stock, Class B Common Stock, Corporate Control, Family Control, Estate Planning, Beneficial Ownership, Alice N. Schwartz, Alles Institute for Medical Research, Corporate Governance